Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2003
07/17/2003US20030135889 Methods for enhancing plant transformation frequencies
07/17/2003US20030135888 Nucleotide sequences for controlling expression of RNA sequences in rice plants; antisense agents; genetic suppressor sequences
07/17/2003US20030135887 Plant bioreactors
07/17/2003US20030135885 Self-processing plants and plant parts
07/17/2003US20030135884 Transgenic seeds expressing amylopullulanase and uses therefor
07/17/2003US20030135883 Synthases/polypeptides for altering concentration or morphology of glucans/polysaccharide/amylose in plants; gene expression inhibition; genetic mapping
07/17/2003US20030135882 Using viral nucleotide sequences/antisense agents to control, improve or enhance gene silencing of phenotypic expression
07/17/2003US20030135881 Quantitative trait loci associated with soybean cyst nematode resistance and uses thereof
07/17/2003US20030135880 Compositions and methods for halogenation reactions
07/17/2003US20030135879 Methods and materials for making and using transgenic dicamba-degrading organisms
07/17/2003US20030135878 Transgenic plants with elevated thioredoxin levels
07/17/2003US20030135877 Sugar and lipid metabolism regulators in plants
07/17/2003US20030135874 Treating pain and urogenital disorders; G-protein coupled receptors; analgesics
07/17/2003US20030135873 Transgenic animal model coding fusion protein comprising nuclear protein and herpes viral vp16 protein; antidiabetic agents; uncoupling proteins
07/17/2003US20030135872 Gene targeting methods and vectors
07/17/2003US20030135870 Maize or soybean enzyme/proteins associated with sugar biosynthesis and metabolism in plants; genetic mapping; plant breeding/agriculture
07/17/2003US20030135869 High throughput genetic screening of lipid and cholesterol processing using fluorescent compounds
07/17/2003US20030135039 Isolating nucleotide sequences from solid phase support comprising hydrophilic graft polymers by adsorbing/desorbing onto from support; for detecting and diagnosing human pathogens
07/17/2003US20030135038 Magnetic pigment
07/17/2003US20030135037 Plasmid comprising chimeric paracrystalline surface layer protein fused to infectious hematopoietic necrosis virial proteins; nonpathogenic gene transfer vechile
07/17/2003US20030135036 Platelet glycoprotein v gene and uses
07/17/2003US20030135035 Human ZZAP1 protein
07/17/2003US20030135033 Compounds and methods for the identification and/ or validation of a target
07/17/2003US20030135032 Nucleic acids that encode enzymes required for the biosynthesis of pyridine-2,6-bis(thiocarboxylate) for reducing amounts of copper, radionuclide, and/or carbon tetrachloride in soils and/or water
07/17/2003US20030135028 Human serine protease and serpin polypeptides
07/17/2003US20030135026 Compounds and methods for diagnosis of tuberculosis
07/17/2003US20030134865 Modulation of histone deacetylase
07/17/2003US20030134818 Lyophilizable and enhanced compacted nucleic acids
07/17/2003US20030134817 SIV derived lentiviral vector systems
07/17/2003US20030134816 Compound capable of modulating the activity and/or expression of hr44, for use in therapy. Hr44 has been cloned from human retinal tissue
07/17/2003US20030134815 Adenovirus mediated transfer of genes to the gastrointestinal tract. In particular, the present invention relates to a method of recombinant, replication-deficient adenovirus mediated transfer of therapuetic genes to the
07/17/2003US20030134814 Isolated nucleic acids molecules, designated 18080 nucleic acid molecules, which encode serine carboxypeptidase members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 18080 nucleic acid
07/17/2003US20030134812 Bladder and lower urinary tract syndromes, particularly, irrative symptoms, and to a method of treating same using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists. The invention further relates to a method of screening compounds
07/17/2003US20030134811 Methods and compositions comprising hydroxyapatite useful for the administration of therapeutic agents
07/17/2003US20030134810 Delivery of pharmacologically active agents associated with polymeric biocompatible materials. Compositions comprising a first, negatively charged pharmacologically active agent such as an oligonucleotide and a polycationic polymer such as
07/17/2003US20030134809 Modulating the expression of ABC transporter MHC 1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding ABC transporter MHC 1. Methods of using these compounds for
07/17/2003US20030134806 Method and reagent for the inhibition of grid
07/17/2003US20030134791 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134787 Engineered to noncovalently bind to heat shock proteins; (ii) to compositions comprising such conjugate peptides, optionally bound to heat shock protein; and (iii) to methods of using such compositions to induce an immune response in a subject in
07/17/2003US20030134776 Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease
07/17/2003US20030134750 In a multiply-twisted helix including having a hierarchical structure in which a linear structure as an element of a the spiral structure of the lowest layer being N, the interval of bonds between m-th degree layers in the multiply-twisted helix
07/17/2003US20030134430 Novel amino acid sequences for human caenorhabditis elegans-like protein polypeptides
07/17/2003US20030134424 For implanting/transfecting monodispersed silicon particles joined to DNA into target tissue, cell or the blood stream
07/17/2003US20030134423 Lipid aggregates (liposomes) for transfection of nucleic acids
07/17/2003US20030134421 Methods for mutating genes in cells and animals using insertional mutagenesis
07/17/2003US20030134412 Method for isolating plasmids from suspended bacterial or yeast cells
07/17/2003US20030134404 Heating the mixture of empty and packaged capsids of adeno-associated virus (AAV) to a temperature of between 40-70 degree C. and adjusting the pH value of the mixture between 4-7 to remove empty AAV virus capsid from the mixture
07/17/2003US20030134403 An expression vector containing a promoter operably linked to a nucleic acid that encodes a prokaryotic enzyme that has both epimerase and reductase activity to catalyze guanosine-4-keto-6-deoxymemmonse to GDP-fucose
07/17/2003US20030134402 Process for producing optically active 4-halo-3-hydroxybutanoate
07/17/2003US20030134401 Process for the stereoselective preparation of functionalized vicinal diols
07/17/2003US20030134400 Isolation of genes that encode enzymes (Delta 4-desaturase) involved in the conversion of adrenic acid to omega 6-docosapentaenoic acid and omega 3-docosapentaenoic acid to docosahexaenoic acid
07/17/2003US20030134398 Mitomycin biosynthetic gene cluster
07/17/2003US20030134397 Culturing a coryneform bacterium which has been modified to increase intracellular pyruvate carboxylase activity and L-glutamic acid producing ability in a medium to produce and accumulate L-glutamic acid in culture
07/17/2003US20030134392 Microorganisms and methods for overproduction of DAHP by cloned Pps gene
07/17/2003US20030134391 Highly-expressed and highly active recombinant silicatein enzyme, silicatein isolated from natural source after gene induction
07/17/2003US20030134390 An isolated polynucleotide molecule encoding an IL-21 antagonist polypeptide of specefic amino acid sequence; culturing
07/17/2003US20030134389 A polypeptide identified as fibroblast growth factor/heparin binding growth factor referred to as FGF-13 for promoting wound healing, to prevent neuronal damage associated with stroke, skin aging and to stimulate angiosenesis
07/17/2003US20030134387 Vertebrate globin
07/17/2003US20030134386 A fibronectin type III (Fn3) monobody polypeptide consisting of two to six beta -strand domains with a loop region linked between each beta-strand domain, and such polypeptide is capable of binding to a target molecule
07/17/2003US20030134385 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134384 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134383 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134382 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134381 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134380 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134379 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide
07/17/2003US20030134378 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134377 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide
07/17/2003US20030134376 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134375 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134374 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134373 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134372 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide
07/17/2003US20030134370 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134369 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134368 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134367 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134366 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134365 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134364 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134363 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134361 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134360 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134359 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134357 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134356 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134355 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134354 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134353 Recombinant dimorphic fungal cell
07/17/2003US20030134352 Enhancing the in vitro renaturation of a protein or polypeptide expressed by recombinant DNA techniques
07/17/2003US20030134351 Intracellular proteins, messenger/signaling/hormone proteins and viral proteins
07/17/2003US20030134350 Zinc finger domain recognition code and uses thereof
07/17/2003US20030134349 Enzymes for the detection of nucleic acid sequences
07/17/2003US20030134348 Recombinant bioluminescent bacteria Escherichia coli DH5@/pSodaLux (EBHJ1) [KCTC 10098BP] for monitoring oxidative stress
07/17/2003US20030134329 Cross-species bioactive peptides
07/17/2003US20030134322 Solid phase thermoplastic or thermosetting resin substrate having a DNA or RNA embedded therein for hybridization assays and immunoassays to detect antinucleic acid antibody
07/17/2003US20030134321 High resolution DNA detection methods and devices
07/17/2003US20030134319 Amino acid sequences of peptides that are encoded by genes within the human genome, the kinase peptides